154 related articles for article (PubMed ID: 7669665)
21. Erythroleukemia: a comparison between the previous FAB approach and the WHO classification.
Park S; Picard F; Azgui Z; Viguie F; Merlat A; Guesnu M; Leblond V; Dreyfus F
Leuk Res; 2002 May; 26(5):423-9. PubMed ID: 11916513
[TBL] [Abstract][Full Text] [Related]
22. Enhanced growth of clonogenic cells from acute myeloblastic leukaemia by erythropoietin.
Motoji T; Hoshino S; Ueda M; Takanashi M; Masuda M; Nakayama K; Oshimi K; Mizoguchi H
Br J Haematol; 1990 May; 75(1):60-7. PubMed ID: 2375925
[TBL] [Abstract][Full Text] [Related]
23. A case of de novo early erythroblastic leukemia supporting a proposal of AML M6 'variant'.
Yonezumi M; Miyagishima T; Kudo M; Choi GH; Kishimoto A; Miura Y; Nakagawa M; Okabe M
Leuk Lymphoma; 2000 Nov; 39(5-6):667-8. PubMed ID: 11392312
[No Abstract] [Full Text] [Related]
24. Erythroleukemia: a need for a new definition.
Park S; Picard F; Dreyfus F
Leukemia; 2002 Aug; 16(8):1399-401. PubMed ID: 12145675
[TBL] [Abstract][Full Text] [Related]
25. Erythroleukemia: a review of 15 cases meeting 1985 FAB criteria and survey of the literature.
Atkinson J; Hrisinko MA; Weil SC
Blood Rev; 1992 Dec; 6(4):204-14. PubMed ID: 1486289
[TBL] [Abstract][Full Text] [Related]
26. Mixed colony formation composed of erythroblasts and myeloblasts by leukemic blast progenitors in patients with erythroleukemia.
Nara N; Tanikawa S; Shiina S
Exp Hematol; 1993 Jan; 21(1):98-102. PubMed ID: 8417964
[TBL] [Abstract][Full Text] [Related]
27. The efficient generation of immunocompetent dendritic cells from leukemic blasts in acute myeloid leukemia: a local experience.
Bagheri K; Alimoghadam K; Pourfathollah AA; Hassan ZM; Hajati J; Moazzeni SM
Pathol Oncol Res; 2009 Jun; 15(2):257-67. PubMed ID: 18807213
[TBL] [Abstract][Full Text] [Related]
28. Acute megakaryoblastic leukaemia: a national clinical and biological study of 53 adult and childhood cases by the Groupe Français d'Hématologie Cellulaire (GFHC).
Duchayne E; Fenneteau O; Pages MP; Sainty D; Arnoulet C; Dastugue N; Garand R; Flandrin G; ;
Leuk Lymphoma; 2003 Jan; 44(1):49-58. PubMed ID: 12691142
[TBL] [Abstract][Full Text] [Related]
29. Familial acute myeloid leukemia and DiGuglielmo syndrome.
Siebert R; Jhanwar S; Brown K; Berman E; Offit K
Leukemia; 1995 Jun; 9(6):1091-4. PubMed ID: 7596175
[TBL] [Abstract][Full Text] [Related]
30. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML.
Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH
Leukemia; 1993 May; 7(5):688-95. PubMed ID: 8483320
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis and characterization of acute erythroleukemia subsets by determining the percentages of myeloblasts and proerythroblasts in 69 cases.
Kowal-Vern A; Mazzella FM; Cotelingam JD; Shrit MA; Rector JT; Schumacher HR
Am J Hematol; 2000 Sep; 65(1):5-13. PubMed ID: 10936857
[TBL] [Abstract][Full Text] [Related]
32. Derivative (1;7)(q10;p10) in a patient with de novo acute erythroblastic leukemia (AML-M6).
Obara N; Shinagawa A; Komatsu T; Abe T; Ninomiya H
Cancer Genet Cytogenet; 1999 Nov; 115(1):62-4. PubMed ID: 10565302
[TBL] [Abstract][Full Text] [Related]
33. Growth factor-independent 1B gene (GFI1B) is overexpressed in erythropoietic and megakaryocytic malignancies and increases their proliferation rate.
Elmaagacli AH; Koldehoff M; Zakrzewski JL; Steckel NK; Ottinger H; Beelen DW
Br J Haematol; 2007 Jan; 136(2):212-9. PubMed ID: 17156408
[TBL] [Abstract][Full Text] [Related]
34. Distinct cytogenetic and clinicopathologic features in acute myeloid leukemia after occupational exposure to pesticides and organic solvents.
Fagioli F; Cuneo A; Piva N; Carli MG; Previati R; Balboni M; Tomasi P; Cariani D; Scapoli G; Castoldi G
Cancer; 1992 Jul; 70(1):77-85. PubMed ID: 1606550
[TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibody anti-MPO is useful in recognizing minimally differentiated acute myeloid leukaemia.
Praxedes MK; De Oliveira LZ; Pereira Wda V; Quintana IZ; Tabak DG; De Oliveira MS
Leuk Lymphoma; 1994 Jan; 12(3-4):233-9. PubMed ID: 8167554
[TBL] [Abstract][Full Text] [Related]
36. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
37. Morphologic, immunologic and cytogenetic studies in erythroleukaemia: evidence for multilineage involvement and identification of two distinct cytogenetic-clinicopathological types.
Cuneo A; Van Orshoven A; Michaux JL; Boogaerts M; Louwagie A; Doyen C; Dal Cin P; Fagioli F; Castoldi G; Van den Berghe H
Br J Haematol; 1990 Jul; 75(3):346-54. PubMed ID: 2386768
[TBL] [Abstract][Full Text] [Related]
38. Acute erythroleukaemia with L3 morphology and the 14q+ chromosome.
Ekblom M; Elonen E; Vuopio P; Heinonen K; Knuutila S; Gahmberg CG; Andersson LC
Scand J Haematol; 1982 Jul; 29(1):75-82. PubMed ID: 6956958
[TBL] [Abstract][Full Text] [Related]
39. Interstitial 9q deletion in T-lymphoid/myeloid biphenotypic leukaemia.
Akashi K; Shibuya T; Harada M; Oogami A; Teshima T; Takamatsu Y; Kikuchi M; Niho Y
Br J Haematol; 1992 Feb; 80(2):172-7. PubMed ID: 1550772
[TBL] [Abstract][Full Text] [Related]
40. Erythroblastic sarcoma presenting as bilateral ovarian masses in an infant with pure erythroid leukemia.
Wang HY; Huang LJ; Liu Z; Garcia R; Li S; Galliani CA
Hum Pathol; 2011 May; 42(5):749-58. PubMed ID: 21237494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
